Researcher
Peter Vandenberghe
- Disciplines:Genetics, Systems biology, Medical imaging and therapy, Molecular and cell biology, Other paramedical sciences
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Responsible
From1 Jan 2008 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → Today
Projects
1 - 10 of 19
- Establishing an evidence ecosystem for blood donation deferral criteria in men who have sex with menFrom9 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Map, Join and Drive European Activities for Advanced Therapy Medicinal Product Development and Implementation for Patient and Society BenefitFrom1 Jan 2024 → TodayFunding: Horizon Europe - Health
- PhD project to identify the immune signature after CAR T-cells treatment.From5 Nov 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- In-depth investigation of patient immune signature after CD19 CAR T-cell therapyFrom1 Mar 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Integrated PK/PM Model-based Medication Dosing Assist App(lication) in KlinischWerkStation (KWS). Validation Studies of Tacrolimus in (Solid) Organ TransplantationFrom1 Jan 2021 → 31 Dec 2023Funding: IOF - technology validation in lab
- Mechanisms and Diagnosis of Mast Cell and Basophil Activation in Rare Hypersensitivity DisordersFrom1 Nov 2020 → TodayFunding: BOF - doctoral mandates
- Tracking Multiple Myeloma by low-pass sequencing of circulating cell free DNAFrom1 Mar 2019 → 1 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Circulating cell-free DNA as an alternative gateway to the genetic features of multiple myeloma and as a surrogate marker for disease burden in multiple myeloma.From1 Mar 2019 → 29 Feb 2024Funding: Nonprofit institution or equivalents
- Circulating cell-free DNA: a novel gateway to the genome of Hodgkin/Reed-Sternberg cells in Hodgkin Lymphoma?From1 Jan 2017 → 31 Dec 2020Funding: Foundations, funds and other with scientific goal
Publications
21 - 30 of 229
- Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cells(2021)
Authors: Peter Vandenberghe
- Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myelogenous Leukaemia: A Retrospective Study and Review of the Literature(2021)
Authors: Nancy Boeckx, Timothy Devos, Peter Vandenberghe, Gregor Verhoef
Pages: 52 - 58 - BIRD-2, a BH4-domain-targeting peptide of Bcl-2, provokes Bax/Bak-independent cell death in B-cell cancers through mitochondrial Ca2+-dependent mPTP opening(2021)
Authors: Martijn Kerkhofs, Rita La Rovere, Ann Janssens, Peter Vandenberghe, Jan Parys, Geert Bultynck
- Ultra-low coverage whole genome sequencing of ccfDNA in multiple myeloma: A tool for laboratory routine?(2021)
Authors: Michel Delforge, Thomas Tousseyn, Nancy Boeckx, Lucienne Michaux, Joris Vermeesch, Peter Vandenberghe, Barbara Dewaele
Pages: 100380 - Noninvasive prenatal testing detected acute myeloid leukemia in paucisymptomatic pregnant patient(2020)
Authors: Lucienne Michaux, Johan Maertens, Thomas Tousseyn, Liesbeth Lenaerts, Joris Vermeesch, Peter Vandenberghe, Barbara Dewaele
Pages: 1924 - 1927 - In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy(2020)
Authors: Lukas Marcelis, Koen Debackere, Peter Vandenberghe, Gregor Verhoef, Francesca Bosisio, Xavier Sagaert, Daan Dierickx, Thomas Tousseyn
Pages: 1751 - 1766 - Ultra-low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma(2020)
Authors: Lieselot Buedts, Jia Ding, Michel Delforge, Joris Vermeesch, Nancy Boeckx, Thomas Tousseyn, Lucienne Michaux, Peter Vandenberghe, Barbara Dewaele
Pages: 465 - 471 - Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma(2020)
Authors: Anne Uyttebroeck, Peter Vandenberghe
Pages: 1685 - 1695 - The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants(2020)
Authors: Anne Uyttebroeck, Peter Vandenberghe
- FER and FES tyrosine kinase fusions in follicular T-cell lymphoma(2020)
Authors: Koen Debackere, Thomas Tousseyn, Lukas Marcelis, Daan Dierickx, Peter Vandenberghe, Lucienne Michaux, Jan Cools
Pages: 584 - 588